MX2017005416A - Composiciones nutritivas que comprenden sn-1(3) monoacilgliceroles para usar en el tratamiento de retrasos del crecimiento en infantes o niños. - Google Patents

Composiciones nutritivas que comprenden sn-1(3) monoacilgliceroles para usar en el tratamiento de retrasos del crecimiento en infantes o niños.

Info

Publication number
MX2017005416A
MX2017005416A MX2017005416A MX2017005416A MX2017005416A MX 2017005416 A MX2017005416 A MX 2017005416A MX 2017005416 A MX2017005416 A MX 2017005416A MX 2017005416 A MX2017005416 A MX 2017005416A MX 2017005416 A MX2017005416 A MX 2017005416A
Authority
MX
Mexico
Prior art keywords
monoacylglycerols
treatment
infants
children
growth delay
Prior art date
Application number
MX2017005416A
Other languages
English (en)
Inventor
Ameye Laurent
Cruz-Hernandez Cristina
Lucia Garcia-Rodenas Clara
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2017005416A publication Critical patent/MX2017005416A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pediatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a una composición nutritiva que comprende sn-1(3) monoacilgliceroles para usar en la prevención/tratamiento del retraso del crecimiento y/o la promoción del crecimiento de un infante o niño, como un niño pequeño, tal como infantes prematuros y/o con bajo peso al nacer.
MX2017005416A 2014-10-27 2015-10-19 Composiciones nutritivas que comprenden sn-1(3) monoacilgliceroles para usar en el tratamiento de retrasos del crecimiento en infantes o niños. MX2017005416A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14190532 2014-10-27
PCT/EP2015/074113 WO2016066459A1 (en) 2014-10-27 2015-10-19 Nutritional compositions comprising sn-1(3) monoacylglycerols for use in the treatment of growth delay in infants or children

Publications (1)

Publication Number Publication Date
MX2017005416A true MX2017005416A (es) 2017-07-26

Family

ID=51795554

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017005416A MX2017005416A (es) 2014-10-27 2015-10-19 Composiciones nutritivas que comprenden sn-1(3) monoacilgliceroles para usar en el tratamiento de retrasos del crecimiento en infantes o niños.

Country Status (10)

Country Link
US (1) US20180280337A1 (es)
EP (1) EP3212180A1 (es)
CN (1) CN107072275A (es)
AU (1) AU2015340902A1 (es)
BR (1) BR112017007362A2 (es)
MX (1) MX2017005416A (es)
PH (1) PH12017500466A1 (es)
RU (1) RU2017118219A (es)
WO (1) WO2016066459A1 (es)
ZA (1) ZA201703638B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190118556A (ko) * 2016-12-23 2019-10-18 바스프 에이에스 악액질의 예방 및/또는 치료용 오메가-3 지방산 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1660065A (zh) * 1997-03-27 2005-08-31 布里斯托尔-迈尔斯斯奎布公司 二十二碳六烯酸和花生四烯酸促进不足月婴儿生长的用途
US6620427B2 (en) * 2001-04-24 2003-09-16 Abbott Laboratories Method for improving bone mineralization
EP2258218A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
ES2875458T3 (es) * 2010-12-29 2021-11-10 Abbott Lab Producto nutricional para uso en la reducción de la incidencia de enterocolitis necrosante en un lactante, niño pequeño o niño
EP2508180A1 (en) * 2011-04-04 2012-10-10 Nestec S.A. Sn-1(3) Monoacylglycerides and lipid absorption

Also Published As

Publication number Publication date
RU2017118219A (ru) 2018-11-29
WO2016066459A1 (en) 2016-05-06
BR112017007362A2 (pt) 2017-12-19
RU2017118219A3 (es) 2019-05-23
EP3212180A1 (en) 2017-09-06
PH12017500466A1 (en) 2017-07-31
ZA201703638B (en) 2019-02-27
US20180280337A1 (en) 2018-10-04
CN107072275A (zh) 2017-08-18
AU2015340902A1 (en) 2017-03-30

Similar Documents

Publication Publication Date Title
PH12017550040A1 (en) Compositions for use in the prevention or treatment of gastrointestinal infections/inflammations in infants or young children
PH12016500764B1 (en) Compositions for use in the prevention or treatment of urt infections in infants or young children at risk
PH12016500773A1 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by c-section
PH12017550044A1 (en) Compositions for use in the prevention or treatment of otitis or bronchitis in infants or young children
ZA201703637B (en) Nutritional compositions comprising sn-1 (3) monoacylglycerols for use in the treatment of malabsorption or maldigestion in infants or young children
PH12018501325A1 (en) Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat a health disorder by increasing glp-1 secretion
PH12017550039A1 (en) Compositions for use in improving stool consistency or frequency in infants or young children
PH12016500610A1 (en) Synthetic nutritional compositions especially adapted for male and female infants and young children
PH12017500387A1 (en) Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition
PH12018501324A1 (en) COMPOSITIONS COMPRISING 2FL AND LNnT TO CONTROL FOOD INTAKE AND GROWTH IN INFANTS OR YOUNG CHILDREN
PH12015502543B1 (en) Anti-regurgitation composition maintaining gut motility
PH12020550465A1 (en) Compositions comprising at least one n-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young children
PH12017500202A1 (en) Nutritional composition with low content of medium-chain fatty acids in specific proportions, and its uses
PH12018500953A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
PH12019500092A1 (en) Nutritional compositions for infants and/or young children comprising oligosaccharides
PH12018500924A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
PH12017500466A1 (en) Nutritional compositions comprising sn-1(3) monoacylglycerols for use in the treatment of growth delay in infants or children
PH12018500890A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
MX2018006296A (es) Composiciones nutritivas y formulas infantiles para promover la mielinizacion en el cerebro.
MX2018006290A (es) Composiciones nutritivas y formulas infantiles para promover la mielinizacion en el cerebro.
PH12017500632B1 (en) Infant nutrition with hydrolysed protein and palmitic acid
PH12016502055A1 (en) Delivery mode specific synthetic nutritional compositions and nutritional systems comprising them
PH12016500701A1 (en) Synthetic milk compositions for infants less than three months old and for infants and children more than three months for ensuring optimal growth and preventing obesity
NZ753208A (en) Anti-regurgitation composition maintaining gut motility